Skip to content

Clinical trials

Phase 2 Skin Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Neoplasms Phase: Phase 2 Country / region: United States Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20033
20043
20054
20076
20086
20093
20102
20119
20132
20144
20152
20161
20171
20181
20192
20204
20213
20222
20232
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Terminated18
Active, not recruiting11
Recruiting4
Withdrawn3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)21
H. Lee Moffitt Cancer Center and Research Institute7
Massachusetts General Hospital5
Memorial Sloan Kettering Cancer Center5
M.D. Anderson Cancer Center4
Genmab2
Point Therapeutics2
Stanford University2
The Center for Clinical and Cosmetic Research2
University of Arizona2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Neoplasms78
Melanoma40
Carcinoma, Squamous Cell9
Cutaneous Squamous Cell Carcinoma9
Neoplasms8
Basal Cell Carcinoma7
Neoplasm Metastasis5
Carcinoma, Merkel Cell4
Keratosis, Actinic4
HIV Infections3

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.